RxDoctor Payments Data

Kellie Sanders-Kizer, MD

Family Medicine · Three Rivers, MINPI 1972612174

Payments from drug & device makers

$498in general payments, 2019–2025

Across 35 payments — averaging $14.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$213
  • AstraZeneca$87
  • Johnson & Johnson$31
  • Sanofi-aventis U.S. LLC$29
  • Mylan Specialty L.p.$21
  • Radius Health, Inc.$19
  • plus $98 from 7 others

What the payments were for

  • Food & beverage$498100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$498 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$37,394
Medicare patients
190
Services billed
481

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide68$75,568
TrulicityDulaglutide61$70,367
EliquisApixaban34$38,526
OzempicSemaglutide32$37,689
JardianceEmpagliflozin13$16,640
Spiriva RespimatTiotropium Bromide17$12,343
FarxigaDapagliflozin Propanediol11$8,610
XareltoRivaroxaban11$7,422
LinzessLinaclotide12$7,368
SymbicortBudesonide/Formoterol Fumarate26$5,738
Breo ElliptaFluticasone/Vilanterol13$5,316
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$4,513
Albuterol Sulfate HfaAlbuterol Sulfate83$2,847
Omeprazole118$1,981
Gabapentin148$1,906

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$13$145,935129 claims
Novo NordiskOzempic$213$37,68932 claims
Boehringer IngelheimJardiance, Spiriva Respimat$13$28,98330 claims
AstraZenecaFarxiga, Symbicort$87$14,34837 claims
Johnson & JohnsonXarelto$31$7,42211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Three Rivers

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →